Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Brigham and Women's Hospital
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Daiichi Sankyo
HealthPartners Institute
Stanford University
Mayo Clinic
Incyte Corporation
University of Washington
City of Hope Medical Center
Tempus AI
Brown University
British Columbia Cancer Agency
Washington University School of Medicine
University of California, Irvine
Tongji Hospital
Stony Brook University
Elevation Oncology
Optimal Health Research
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zhejiang Provincial People's Hospital
Erasmus Medical Center
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
Wake Forest University Health Sciences
DEKK-TEC, Inc.
MetiMedi Pharmaceuticals
Sun Yat-sen University
Tetra Bio-Pharma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Amgen
AIO-Studien-gGmbH
Cornerstone Pharmaceuticals
Alliance for Clinical Trials in Oncology
InSightec
Memorial Sloan Kettering Cancer Center
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Associazione Oncologia Traslazionale
Hellenic Cooperative Oncology Group
Sheba Medical Center
GE Healthcare
Pharmacyclics LLC.